Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, PLW

BankShift Unveils Patent-Pending Innovation to Revolutionize Embedded Banking: Brand On Banking


PORTLAND, Ore., April 11, 2024 /PRNewswire/ -- ShiftCents, Inc. aka BankShift, the innovative emerging leader in digital banking solutions, proudly announces a significant milestone in the realm of embedded banking: the attainment of a patent-pending status for its revolutionary Brand On Banking technology. This pioneering development marks a watershed moment in the evolution of embedded banking, poised to redefine the landscape of financial interactions between brands, financial institutions, and individuals.

BankShift's Brand On Banking innovation represents a paradigm shift in the way financial institutions and businesses engage with their customers. By seamlessly integrating a business' brand within the banking experience, this patent-pending technology not only enhances brand visibility but also fosters deeper customer engagement and loyalty. The unique blend of financial services and brand presence opens new avenues for revenue generation while reinforcing customer affinity towards both the brand and the financial institution without impacting the customers' wallet for rewards.

With this patent-pending status, BankShift reaffirms its commitment to innovation and excellence in the embedded banking sector. The rigorous development process and meticulous attention to detail underscore BankShift's dedication to delivering cutting-edge solutions that empower financial institutions and businesses to thrive in the digital age.

"As an inventor and pioneer in embedded banking ecosystems, BankShift is thrilled to achieve patent-pending status for our Brand on Banking innovative technology," said Rob Thacher, Founder and CEO of BankShift. "This milestone underscores our relentless pursuit of innovation and our commitment to empowering our banking and brand partners with transformative solutions that drive growth and success."

BankShift invites financial institutions and businesses to explore the possibilities unlocked by its patent-pending Brand On Banking innovative technology. Contact us today to learn more about how BankShift can revolutionize your embedded banking experience and elevate your brand presence.

About BankShift:
BankShift is emerging as a pioneering force in embedded banking, poised to redefine the landscape of financial interactions through advanced technology and strategic alliances. Anchored in customer-centric principles and a spirit of innovation, BankShift empowers both financial institutions and businesses to flourish in today's ever-evolving digital terrain. Our exclusive brand-on-banking features are crafted to foster loyalty and drive growth, propelling our partners towards unprecedented success. 

For media inquiries, please contact:
Bernice Gardner
Public Relations
BankShift
[email protected]

SOURCE ShiftCents, Inc.


These press releases may also interest you

at 20:14
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC)
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE joins Mastercard's Priceless Planet Coalition
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
E&R Engineering Corp. Unveils Cutting-Edge Solutions at Semicon SEA 2024 in Kuala Lumpur
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

More news about Science and technology...


News published on and distributed by: